April 17, 2024

Backet Hat

Just another WordPress site

Erythropoietin Drugs Market 2022-27 | Trends, Share, Demand, Growth and Analysis

According to the latest report by IMARC Group “Erythropoietin Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027“, The global erythropoietin drugs market size reached US$ 9.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 13.8 Billion by 2027, exhibiting a growth rate (CAGR) of 5.75% during 2022-2027.

Erythropoietin (EPO) represents a hormone secreted by kidneys, which stimulates red blood cell (RBC) production. Its deficiency may cause low hemoglobin levels and various other medical conditions. EPO drugs or EPO stimulating agents (ESAs) are produced synthetically by applying recombinant Deoxyribonucleic acid (DNA) technology. They are typically administered through the intramuscular route and absorbed by the bloodstream to prompt RBC production. EPO drugs are commonly given to patients undergoing chemotherapy, chronic renal failure, antiviral drug therapy, etc.

Request for a free sample copy of this report: https://www.imarcgroup.com/erythropoietin-drugs-market/requestsample

Market Trends:

The increasing number of individuals with anemia due to cancer, chronic kidney disease (CKD), prematurity, etc., is primarily driving the demand for EPO drugs. Moreover, these drugs are also used for treating zidovudine among patients with human immunodeficiency virus (HIV) infection. Additionally, with the growing geriatric population across the globe, there is an elevating requirement for surgical interventions, which is encouraging product use for minimizing allogeneic blood transfusions after surgical procedures. Furthermore, the rising utilization of ESAs as a novel therapeutic agent for research purposes is also expanding their applications in treating numerous conditions, such as spinal cord injury (SCI), diabetes, acute kidney injury (AKI), etc. Apart from this, the increasing popularity of minimally invasive (MI) procedures is anticipated to further bolster the EPO drugs market over the forecasted period.

Breakup by Drug Class:

  • Biologics
  • Biosimilars

Breakup by Product Type:

  • Epoetin-alfa
  • Epoetin-beta
  • Darbepoetin-alfa
  • Others

Breakup by Application:

  • Hematology
  • Kidney Disorder
  • Cancer
  • Others

Breakup by End User:

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • Amgen Inc.
  • Biocon Limited
  • Dr. Reddy’s Laboratories Ltd.
  • F. Hoffmann-La Roche AG
  • Intas Pharmaceuticals Ltd.
  • Johnson & Johnson
  • LG Chem Ltd.
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Limited
  • Teva Pharmaceutical Industries Ltd.

Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/erythropoietin-drugs-market

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US


Email: sales@imarcgroup.com

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal